Tag Archive for PRO/EDR> Chikungunya (02): Americas, Africa
PRO/EDR> Chikungunya (02): Americas, Africa
Chikungunya -- Worldwide/UnknownSaint-Herblain-based Valneva SE announced on 12 Apr 2021 that it had completed recruitment for the pivotal Phase 3 clinical trial of its single-shot chikungunya vaccine candidate, VLA1553.A total of 4131 adults aged 18 or above have been recruited across 44 sites in the USA for the VLA1553-301 trial, which was launched in September 2020. Participants will be followed for 6 months in the pivotal trial. If the trial results are positive, the trial is expected to support Read more [...]
